219 related articles for article (PubMed ID: 33684053)
21. How do we share data in COVID-19 research? A systematic review of COVID-19 datasets in PubMed Central Articles.
Zuo X; Chen Y; Ohno-Machado L; Xu H
Brief Bioinform; 2021 Mar; 22(2):800-811. PubMed ID: 33757278
[TBL] [Abstract][Full Text] [Related]
22. Clinical trials in a COVID-19 pandemic: Shared infrastructure for continuous learning in a rapidly changing landscape.
Hedlin H; Garcia A; Weng Y; He Z; Sundaram V; Bunning B; Balasubramanian V; Cunanan K; Kapphahn K; Gummidipundi S; Purington N; Boulos M; Desai M
Clin Trials; 2021 Jun; 18(3):324-334. PubMed ID: 33535821
[TBL] [Abstract][Full Text] [Related]
23. Use of the Estimand Framework to Manage the Disruptive Effects of COVID-19 on Stroke Clinical Trials.
Yassi N; Hayward KS; Campbell BCV; Churilov L
Stroke; 2021 Nov; 52(11):3739-3747. PubMed ID: 34587797
[TBL] [Abstract][Full Text] [Related]
24. Health informatics and EHR to support clinical research in the COVID-19 pandemic: an overview.
Dagliati A; Malovini A; Tibollo V; Bellazzi R
Brief Bioinform; 2021 Mar; 22(2):812-822. PubMed ID: 33454728
[TBL] [Abstract][Full Text] [Related]
25. Resource implications of preparing individual participant data from a clinical trial to share with external researchers.
Tudur Smith C; Nevitt S; Appelbe D; Appleton R; Dixon P; Harrison J; Marson A; Williamson P; Tremain E
Trials; 2017 Jul; 18(1):319. PubMed ID: 28712359
[TBL] [Abstract][Full Text] [Related]
26. Regulatory Frameworks for Clinical Trial Data Sharing: Scoping Review.
Gudi N; Kamath P; Chakraborty T; Jacob AG; Parsekar SS; Sarbadhikari SN; John O
J Med Internet Res; 2022 May; 24(5):e33591. PubMed ID: 35507397
[TBL] [Abstract][Full Text] [Related]
27. How the COVID-19 pandemic is changing clinical trial conduct and driving innovation in bioanalysis.
Anderson M
Bioanalysis; 2021 Aug; 13(15):1195-1203. PubMed ID: 34275327
[TBL] [Abstract][Full Text] [Related]
28. Clinical trial design during and beyond the pandemic: the I-SPY COVID trial.
I-SPY COVID Consortium
Nat Med; 2022 Jan; 28(1):9-11. PubMed ID: 35058620
[No Abstract] [Full Text] [Related]
29. The COVID-19 pandemic and a reflection on the conduct of clinical trials in times of war.
Pacheco RL; Cabrera Martimbianco AL; Riera R
J Clin Epidemiol; 2021 Apr; 132():131-132. PubMed ID: 33301908
[No Abstract] [Full Text] [Related]
30. The Investigational Clinical Center: a clinical-supportive and patient-centered trial unit model. Ten years of experience through normal and pandemic times of a large pediatric trial center in Italy.
Pontrelli G; Ciabattini M; De Crescenzo F; Biondi I; Cocchiola R; Copponi G; Frillici C; Molinari F; Rocchi F; Simonetti A; Rossi P; Livadiotti S
Ital J Pediatr; 2021 Jul; 47(1):156. PubMed ID: 34256815
[TBL] [Abstract][Full Text] [Related]
31. Enabling data sharing and utilization for African population health data using OHDSI tools with an OMOP-common data model.
Kiwuwa-Muyingo S; Todd J; Bhattacharjee T; Taylor A; Greenfield J
Front Public Health; 2023; 11():1116682. PubMed ID: 37361151
[TBL] [Abstract][Full Text] [Related]
32. Challenges and Lessons Learned From COVID-19 Trials: Should We Be Doing Clinical Trials Differently?
Janiaud P; Hemkens LG; Ioannidis JPA
Can J Cardiol; 2021 Sep; 37(9):1353-1364. PubMed ID: 34077789
[TBL] [Abstract][Full Text] [Related]
33. Role of the Clinical Data Managers During the COVID-19 Pandemic: An Overview.
Sajja R
Rev Recent Clin Trials; 2023; 18(1):41-45. PubMed ID: 36503462
[TBL] [Abstract][Full Text] [Related]
34. Assessing the impact of COVID-19 on registered interventional clinical trials.
Hawila N; Berg A
Clin Transl Sci; 2021 May; 14(3):1147-1154. PubMed ID: 33769709
[TBL] [Abstract][Full Text] [Related]
35. Characteristics of Clinical Trials Launched Early in the COVID-19 Pandemic in the US and in France.
Raimond V; Mousquès J; Avorn J; Kesselheim AS
J Law Med Ethics; 2021; 49(1):139-151. PubMed ID: 33966651
[TBL] [Abstract][Full Text] [Related]
36. International transfers of personal data for health research following Schrems II: a problem in need of a solution.
Hallinan D; Bernier A; Cambon-Thomsen A; Crawley FP; Dimitrova D; Medeiros CB; Nilsonne G; Parker S; Pickering B; Rennes S
Eur J Hum Genet; 2021 Oct; 29(10):1502-1509. PubMed ID: 33953344
[TBL] [Abstract][Full Text] [Related]
37. COVID-19 and the generation of novel scientific knowledge: Evidence-based decisions and data sharing.
Perillat L; Baigrie BS
J Eval Clin Pract; 2021 Jun; 27(3):708-715. PubMed ID: 33580747
[TBL] [Abstract][Full Text] [Related]
38. Platform trials to evaluate the benefit-risk of COVID-19 therapeutics: Successes, learnings, and recommendations for future pandemics.
Buenconsejo J; Liao R; Lin J; Singh P; Cooner F; Ghosh S; Gamalo M; Russek-Cohen E; Zariffa N
Contemp Clin Trials; 2023 Sep; 132():107292. PubMed ID: 37454729
[TBL] [Abstract][Full Text] [Related]
39. Ethics and governance challenges related to genomic data sharing in southern Africa: the case of SARS-CoV-2.
Moodley K; Cengiz N; Domingo A; Nair G; Obasa AE; Lessells RJ; de Oliveira T
Lancet Glob Health; 2022 Dec; 10(12):e1855-e1859. PubMed ID: 36309034
[TBL] [Abstract][Full Text] [Related]
40. Mind the clinical-analytic gap: Electronic health records and COVID-19 pandemic response.
Sudat SEK; Robinson SC; Mudiganti S; Mani A; Pressman AR
J Biomed Inform; 2021 Apr; 116():103715. PubMed ID: 33610878
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
